AzTrials
AzTrials

Organ or Tissue Transplant; ComplicationsNCT07394660

The Effect of Remote Reiki Treatment on Hopelessness, Fatigue and Pain in Patients Awaiting Organ Transplantation

A study testing remote reiki in people with Organ or Tissue Transplant; Complications and Reiki, run by Bozok University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The treatment and care of chronic kidney failure is a long-term process, and patients are significantly affected by this condition. The fact that patients spend much of their daily lives attending hemodialysis sessions two or three times a week considerably limits their life activities. Read more about this study

Who is it for?
Ages 18 to 70 yearsHealthy volunteers can take part
What is being tested?
remote reiki
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteTurkey (Türkiye)
Study dates
10 Jul 2025to 10 Nov 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Patients who have been undergoing haemodialysis for ≥ 6 months,
  • Aged 18 years or older,
  • Patients with chronic kidney disease,
  • Can speak and understand Turkish and,
  • Have a mobile phone and can use it will be included in the study.

Who cannot join

  • Patients using psychotropic medication will not be included in the study.
  • Patients who are unable to attend regular sessions will be excluded from the study.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Gökmedrese Dialasis Center

    Yozgat, Yozgat, 66100

Other trials in Turkey (Türkiye)

About this study

The treatment and care of chronic kidney failure is a long-term process, and patients are significantly affected by this condition. The fact that patients spend much of their daily lives attending hemodialysis sessions two or three times a week considerably limits their life activities. dition to medical treatment, a non-pharmacological Therefore, individuals may become partially or completely dependent. Coping with various symptoms brought on by this chronic disease, adapting to the restrictions required by treatment, preventing complications, and improving quality of life also bring about physical, cognitive, and psychological challenges. Patients are aware that they can only regain their previous health through organ transplantation; however, since it is uncertain when a suitable donor will be found, they may experience intense feelings of hopelessness. The chronic illness itself and the hemodialysis sessions frequently lead to symptoms such as pain and fatigue. In admethod such as distant Reiki may be supportive in coping with symptoms like hopelessness, fatigue, and pain. Numerous evidence-based studies in the literature have demonstrated that distant Reiki practices support symptom management in many chronic diseases through their effects on the parasympathetic nervous system. However, the effects of distant Reiki on hopelessness, fatigue, and pain in individuals awaiting organ donation have not yet been investigated.

Read the detailed description

Therefore, this study is planned to be conducted as a randomized controlled trial with two groups. Fifty patients awaiting organ donation who meet the inclusion criteria will be included in the study. Data will be collected using the "Personal Information Form," "Beck Hopelessness Scale," "Fatigue Severity Scale," and "Brief Pain Inventory." Analyses will be performed using an appropriate statistical software package. We believe that distant Reiki practices may have positive effects on hopelessness, fatigue, and pain among hemodialysis patients awaiting organ donation. It is known that the majority of nurses worldwide hold Reiki practice certifications and use this method in chronic diseases. The main aim of this study is to support symptom management and strengthen coping mechanisms in individuals through distant Reiki practices.

Being tested
remote reiki
Keywords
reiki, organ transplant, nursing, pain, Hopelessness
Medical subject headings
Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • remote reikiBehavioural

    Patients in the intervention group will be contacted by telephone. They will be provided with a suitable environment. A certified assistant researcher will initiate the remote Reiki application. Each application is expected to last an average of 35-40 minutes. The first remote Reiki session will be conducted on the evening of the patient's haemodialysis day. The sessions will take place three times a week for a total of four weeks. After the application is completed, vital signs will be taken again from the intervention group patients, and the Beck Hopelessness Scale, Fatigue Severity Scale, and Brief Pain Inventory will be completed. The data collection tool will be completed a second time the day after the last application and a third time one month later. The effects of Reiki therapy on hopelessness, fatigue, and pain will be evaluated using the Personal Information Form, Beck Hopelessness Scale, Fatigue Severity Scale, and Brief Pain Inventory.

Study groups in NCT07394660
Study groupRoleWhat they receive
1Experimentalremote reiki
Receives: Behavioral: remote reiki
2No interventioncontrol

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Hopelessness Level

    Hopelessness level will be assessed using the Beck Hopelessness Scale (BHS). The scale consists of 20 items and measures negative expectations about the future. Higher total scores indicate greater levels of hopelessness. Total scale score (0-20) Unit of Measure: Scale total score (0-20)

    Measured: From enrollment to the end of treatment at 8 weeks

  2. Pain Intensity and Pain Interference

    Pain intensity and pain-related interference with daily activities will be assessed using the numeric raito scale (NRS). The instrument evaluates pain severity and its impact on functioning. Pain severity score and pain interference score Unit of Measure: Scale total score (0-10)

    Measured: From enrollment to the end of treatment at 8 weeks

  3. Fatigue Severity

    Fatigue severity will be measured using the Fatigue Severity Scale (FSS), a 9-item self-report questionnaire evaluating the impact of fatigue on daily functioning. Higher scores indicate greater fatigue severity.

    Unit of Measure: Total scale score (1-7)

    Measured: Baseline (first dialysis day), at 4 weeks (end of intervention), and 1 month after the final intervention session

Secondary outcomes (4)
  1. Systolic Blood Pressure

    Description:

    Systolic blood pressure measured under standardized resting conditions using an automated monitor.

    Unit of Measure: mmHg

    Measured: Baseline to 8 weeks

  2. Diastolic Blood Pressure

    Description:

    Diastolic blood pressure measured under standardized resting conditions using an automated monitor.

    Unit of Measure: mmHg

    Measured: Baseline to 8 weeks

  3. Heart Rate

    Description:

    Resting heart rate measured using an automated vital signs monitor. Unit of Measure: beats per minute (bpm)

    Measured: Baseline to 8 weeks

  4. Body Temperature

    Description:

    Body temperature measured using a digital thermometer under standardized conditions.

    Unit of Measure: °C

    Measured: Baseline to 8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Feb 2026
  2. Study start10 Jul 2025
  3. Primary completion10 Aug 2025
  4. Study completion10 Nov 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
This study is planned to be conducted as a randomized controlled trial with two groups.
Masking
None (open label)
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07394660
Sponsor's protocol ID
BozokUnıversity
Other IDs
the author himself
Status last verified
Feb 2026
First submitted
4 Dec 2025
Last updated
6 Feb 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: De-identified individual participant data (IPD) underlying the results reported in publications (including outcome measure data, demographic variables, and relevant clinical variables) will be made available upon reasonable request to the corresponding author. All shared data will be fully anonymized to protect participant confidentiality and will exclude any personally identifiable information.

Publications

  • Bektas Akpinar N, Unal N, Alincak G, Porucu C, Yurtsever S, Karadurmus N. The Power of Reiki: Its Effects on Pain and Biochemical Parameters in Patients Undergoing Bone Marrow Transplantation: A Randomized Prospective Controlled Study. Pain Manag Nurs. 2025 Feb;26(1):e24-e30. doi: 10.1016/j.pmn.2024.08.008. Epub 2024 Sep 19.

    PubMed 39304481

Questions about this trial

What is this clinical trial studying?

A study testing remote reiki in people with Organ or Tissue Transplant; Complications and Reiki, run by Bozok University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Hopelessness Level (time frame: From enrollment to the end of treatment at 8 weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07394660, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Feb 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in